MINNEAPOLIS--(BUSINESS WIRE)--July 25, 2006--MGI PHARMA, INC. (Nasdaq:MOGN - News), a biopharmaceutical company focused in oncology and acute care, today announced that James O. Armitage, M.D., F.A.C.P., F.R.C.P., has been appointed to the MGI PHARMA Board of Directors. Dr. Armitage’s appointment increases the number of independent directors on the Company’s Board to eight.
